Document is current
Any future updates will be listed below
-
Authors
Kaczmarzyk, Jakub R.
Van Alsten, Sarah C.
Cozzo, Alyssa J.
Gupta, Rajarsi
Koo, Peter K.
Troester, Melissa A.
Hoadley, Katherine A.
Saltz, Joel H.
-
Funding
Funding for this research was provided by:
University Cancer Research Fund of North Carolina
Susan G. Komen (OGUNC1202)
National Cancer Institute (R01CA253450)
National Cancer Institute (R01CA253450)
National Cancer Institute (5UH3CA225021)
Breast Cancer Research Foundation (HEI-23-003)
U.S. Department of Defense (HT94252310235)
National Science Foundation (IIS-2212046)
Stony Brook University Provost’s ProFund
Donor support from Bob Beals and Betsy Barton
- License Information
-
More Information
Article History
Received: 15 June 2025
Accepted: 30 December 2025
First Online: 16 January 2026
Competing interests
: The University of North Carolina, Chapel Hill has a license of intellectual property interest in GeneCentric Diagnostics and BioClassifier, LLC, which may be used in this study. The University of North Carolina, Chapel Hill may benefit from this interest that is/are related to this research. The terms of this arrangement have been reviewed and approved by the University of North Carolina, Chapel Hill Conflict of Interest Program in accordance with its conflict of interest policies. J.H.S. and R.G. are co-founders of Chilean Wool, LLC. All other authors declare no competing interests.
